In fact, in melanoma models, as the VPS34 kinase inhibitors SB02024 or SAR405 induced a rise in CCL5, CXCL10 and IFN‐γ in the TME along with an increase in the extent of NK and T‐cell infiltration, the inhibition of melanoma was greatly enhanced. The gene discussed is CCL5; the disease is melanoma.